Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.58
$0.035.22%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -19.16% | -3.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -33.64% | -7.12% | |||
| Operating Income | 33.64% | 7.12% | |||
| Income Before Tax | 33.71% | 5.94% | |||
| Income Tax Expenses | -65.00% | 53.85% | |||
| Earnings from Continuing Operations | 33.75% | 5.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 33.75% | 5.89% | |||
| EBIT | 33.64% | 7.12% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 54.53% | 8.17% | |||
| Normalized Basic EPS | 54.49% | 8.23% | |||
| EPS Diluted | 54.53% | 8.17% | |||
| Normalized Diluted EPS | 54.49% | 8.23% | |||
| Average Basic Shares Outstanding | 45.81% | 2.47% | |||
| Average Diluted Shares Outstanding | 45.81% | 2.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||